PMS PROCHLORPERAZINE INJ 5MG/ML SOLUTION

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Kaufe es jetzt

Fachinformation Fachinformation (SPC)
22-01-2013

Wirkstoff:

PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE)

Verfügbar ab:

PHARMASCIENCE INC

ATC-Code:

N05AB04

INN (Internationale Bezeichnung):

PROCHLORPERAZINE

Dosierung:

5MG

Darreichungsform:

SOLUTION

Zusammensetzung:

PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5MG

Verabreichungsweg:

INTRAMUSCULAR

Einheiten im Paket:

10 X 2ML

Verschreibungstyp:

Prescription

Therapiebereich:

PHENOTHIAZINES

Produktbesonderheiten:

Active ingredient group (AIG) number: 0106181002; AHFS:

Berechtigungsstatus:

MARKETED

Berechtigungsdatum:

1989-12-31

Fachinformation

                                PRESCRIBING INFORMATION
PR
PMS-PROCHLORPERAZINE
Prochlorperazine Maleate Tablets USP
5 mg and 10 mg
Prochlorperazine Suppositories USP
10 mg
Prochlorperazine Mesylate Injection BP
5 mg/mL
ANTIPSYCHOTIC/ANTIEMETIC
PHARMASCIENCE INC.
6111 Royalmount Ave., Suite 100
Montréal, Québec
H4P 2T4
Date of Revision :
January 10, 2013
Control Number: 161362
_ _
_pms-PROCHLORPERAZINE Prescribing information _
_Page 2 of 20 _
TABLE OF CONTENTS
ACTIONS AND CLINICAL PHARMACOLOGY
.......................................................................
3
INDICATIONS AND CLINICAL USE
.........................................................................................
3
CONTRAINDICATIONS
..............................................................................................................
4
WARNINGS
...................................................................................................................................
4
PRECAUTIONS
.............................................................................................................................
5
ADVERSE EFFECTS
....................................................................................................................
7
SYMPTOMS AND TREATMENT OF OVERDOSAGE
........................................................... 10
DOSAGE AND ADMINISTRATION
.........................................................................................
10
AVAILABILITY OF DOSAGE FORMS
....................................................................................
11
Part III: CONSUMER INFORMATION
......................................................................................
13
_ _
_pms-PROCHLORPERAZINE Prescribing information _
_Page 3 of 20 _
PRESCRIBING INFORMATION
PR
PMS-PROCHLORPERAZINE
Prochlorperazine Maleate Tablets USP
5 mg and 10 mg
Prochlorperazine Suppositories USP
10 mg
Prochlorperazine Mesylate Injection BP
5 mg/mL
ACTIONS AND CLINICAL PHARMACOLOGY
Prochlorperazine is a piperazine phenothiazine derivative with
antipsychotic, antiemeti
                                
                                Lesen Sie das vollständige Dokument
                                
                            

Dokumente in anderen Sprachen

Fachinformation Fachinformation Französisch 10-01-2013

Suchen Sie nach Benachrichtigungen zu diesem Produkt